ILK inhibitors, KP392, QLT0267, and T315, can suppress ILK- EMT activity in epithelial ovarian cancer [155]. In vitro studies have also shown that the EGF inhibitor, AG1478, causes EGF-induced EMT in cervical, ovarian, and endometrial cancer [155]. Here, EGF is linked to ovarian carcinoma.